Nasdaq - PDFSEARCH.IO - Document Search Engine

Nasdaq
Results: 4361

#	Item
961	May 16, 2012 Astex Pharmaceuticals to Present at ASCO Annual Meeting DUBLIN, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and de Add to Reading List Source URL: astx.com Language: English
962	October 31, 2012 Astex Pharmaceuticals to Present at EORTC-NCI-AACR DUBLIN, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and de Add to Reading List Source URL: astx.com Language: English
963	Intersect ENT Announces Enrollment of First Patient In Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis Menlo Park, Calif. – Dec. 29, 2014 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicate Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-12-29 18:58:43 Anatomy Sinus Medicine Rhinology Otolaryngology
964	Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results on April 30, 2012 DUBLIN, Calif., April 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to Add to Reading List Source URL: astx.com Language: English
965	October 23, 2012 Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012 DUBLIN, Calif, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical co Add to Reading List Source URL: astx.com Language: English
966	Intersect ENT Appoints Chas McKhann as Chief Commercial Officer Menlo Park, Calif. – February 2, 2015––Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-02-03 12:17:27 Headaches Sinusitis Otolaryngology Sinus Drug-eluting stent Medicine Rhinology General practice
967	FOR IMMEDIATE RELEASE Egencia and International SOS expand their traveller security partnership London – January 27, 2015 – Egencia® the business travel company of Expedia, Inc. (NASDAQ: EXPE) announces the beginni Add to Reading List Source URL: www.egencia.co.uk Language: English - Date: 2015-04-15 15:01:50 Public safety Emergency management Expedia Inc. Expedia Travel agency SOS Business travel Open Travel Alliance Travel International SOS
968	FDA Accepts DACOGEN(R) (Decitabine) sNDA Submission in Acute Myeloid Leukemia DUBLIN, Calif., Jul 13, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and developmen Add to Reading List Source URL: astx.com Language: English Myelodysplastic syndrome Syndromes Acute myeloid leukemia Leukemia Thrombocytopenia Neutropenia Cytarabine Anemia Medicine Oncology Hematopathology
969	April 3, 2013 Astex Pharmaceuticals Pipeline Data Presentations at AACR DUBLIN, Calif., April 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery an Add to Reading List Source URL: astx.com Language: English Astex American Association for Cancer Research Prostate cancer
970	Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at AACR DUBLIN, Calif., April 3, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical c Add to Reading List Source URL: astx.com Language: English Acute myeloid leukemia Myeloid leukemia Myelodysplastic syndrome Astex Decitabine Oncology Medicine Acute leukemia

UPDATE